Clinical And Economic Burden Of Idiopathic Pulmonary Fibrosis

被引:0
|
作者
Raimundo, K. [1 ,2 ]
Chang, E. [2 ]
Broder, M. [2 ]
Carrigan, G. [1 ]
Zazzali, J. [1 ]
Swigris, J. J. [3 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Partnership Hlth Analyt Res LLC, Beverly Hills, CA USA
[3] Natl Jewish Hlth, Denver, CO USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2521
引用
收藏
页数:1
相关论文
共 50 条
  • [41] The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis
    Tomassetti, Sara
    Gurioli, Christian
    Ravaglia, Claudia
    Piciucchi, Sara
    Casoni, Gian Luca
    Romagnoli, Micaela
    Gurioli, Carlo
    Poletti, Venerino
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [42] Clinical Predictors of Survival in Idiopathic Pulmonary Fibrosis
    Kim, Ji Hye
    Lee, Jin Hwa
    Ryu, Yon Ju
    Chang, Jung Hyun
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2012, 73 (03) : 162 - 168
  • [43] The big clinical trials in idiopathic pulmonary fibrosis
    Luppi, Fabrizio
    Spagnolo, Paolo
    Cerri, Stefania
    Richeldi, Luca
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (05) : 428 - 432
  • [44] Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis
    Ohkubo, Hirotsugu
    Fukumitsu, Kensuke
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Takemura, Masaya
    Maeno, Ken
    Ito, Yutaka
    Niimi, Akio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [45] PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS: PREVALENCE AND CLINICAL PROGRESS
    Castria, D.
    Refini, R. M.
    Bargagli, E.
    Mezzasalma, F.
    Pierli, C.
    Rottoli, P.
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (03) : 681 - 689
  • [46] Pulmonary hypertension in idiopathic pulmonary fibrosis: Epidemiology and clinical correlates
    Shorr, AF
    Cors, C
    Lettieri, CJ
    Helman, DL
    Nathan, SD
    [J]. CHEST, 2005, 128 (04) : 218S - 218S
  • [47] Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study)
    Rodriguez-Nieto, Maria Jesus
    Cano-Jimenez, Esteban
    Romero Ortiz, Ana D.
    Villar, Ana
    Morros, Marta
    Ramon, Alba
    Armengol, Silvia
    [J]. PHARMACOECONOMICS, 2023, 41 (08) : 999 - 1010
  • [48] Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study)
    Maria Jesus Rodríguez-Nieto
    Esteban Cano-Jiménez
    Ana D. Romero Ortiz
    Ana Villar
    Marta Morros
    Alba Ramon
    Silvia Armengol
    [J]. PharmacoEconomics, 2023, 41 : 999 - 1010
  • [49] Evaluation Of The Healthcare Burden Of Idiopathic Pulmonary Fibrosis ( ipf) In Fife, Scotland
    Dhasmana, D. J.
    Harrison, F.
    Hartley, T.
    Szapiro, D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [50] Cardiovascular Burden and Medication Use Among Patients With Idiopathic Pulmonary Fibrosis
    Raimundo, Karina
    Broder, Michael
    Chang, Eunice
    Reddy, Sheila
    Papoyan, Elya
    Stauffer, John
    [J]. CHEST, 2016, 150 (04) : 480A - 480A